Douglas CDMO
Auckland, New Zealand
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (9)
○ EMA GMP
○ MHRA GMP
Quick Facts: Douglas CDMO
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Auckland, New Zealand
- Modalities
- Softgel Capsule (pharmaceutical), HPAPI Softgel, Lipid-Based Drug Delivery, Retinoid / Isotretinoin, Oral Liquid Fill
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Douglas CDMO
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSoftgel Capsule (pharmaceutical), HPAPI Softgel, Lipid-Based Drug Delivery, Retinoid / Isotretinoin, Oral Liquid Fill
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (5 modalities)
Recent News 9 articles
Pharma Matters Q&A: Douglas CDMO - Contract Pharma
Packaging Is Where Timelines Hold—or Slip - Contract Pharma
What’s New: Business Updates from Across the OSD Sector - Contract Pharma
Contract Pharma Sits Down with Christoph Buerki of Novartis GlobalBiotech Cooperations - Contract Pharma
Contract Pharma Talks with Scott Rizzo on CoreRx’s Acquisition of Societal - Contract Pharma
Good as Gold: Douglas CDMO - Contract Pharma
Nasal Drug Delivery CDMO Market Size, Trend, Revenue Analysis Report 2026 to 2035 - insightaceanalytic.com
Videobite: Contract Pharma Sits Down with Peter Surman of Douglas CDMO - Contract Pharma
Porton at 20: Building a Global CDMO for the Next Era of Pharma - Contract Pharma
Frequently Asked Questions About Douglas CDMO
What is Douglas CDMO's CDMO Signal Score?
Douglas CDMO has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Douglas CDMO for a manufacturing program?
Use the free AI matchmaker to compare Douglas CDMO against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: